Prolonged allograft survival of strong pretransplant immune responders treated with ATG.
D000920:Antibody-Dependent Cell Cytotoxicity; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology; D012397:Rosette Formation; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D014181:Transplantation Immunology
D000961:Antilymphocyte Serum